Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Prediction of surgical outcome after aortic valve replacement.

Mistiaen W, Van Cauwelaert P, Muylaert P.

Acta Chir Belg. 2012 Jan;112(1):59-64.

PMID:
22442911
2.

An evaluation of underbody forced-air and resistive heating during hypothermic, on-pump cardiac surgery.

Engelen S, Himpe D, Borms S, Berghmans J, Van Cauwelaert P, Dalton JE, Sessler DI.

Anaesthesia. 2011 Feb;66(2):104-10. doi: 10.1111/j.1365-2044.2010.06609.x.

3.

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators.

N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18. Erratum in: N Engl J Med. 2013 Feb 7;368(6):584.

4.

A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly.

Mistiaen W, Van Cauwelaert P, Muylaert P, De Worm E.

J Cardiovasc Surg (Torino). 2009 Apr;50(2):233-7. Epub 2008 Oct 24.

5.
6.

Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy.

Lemmens K, Segers VF, Demolder M, Michiels M, Van Cauwelaert P, De Keulenaer GW.

Eur J Heart Fail. 2007 Apr;9(4):352-6. Epub 2006 Nov 28.

7.

Histological evaluation of autophagic cell death in calcified aortic valve stenosis.

Somers P, Knaapen M, Kockx M, van Cauwelaert P, Bortier H, Mistiaen W.

J Heart Valve Dis. 2006 Jan;15(1):43-7; discussion 48.

PMID:
16480011
8.

Risk factors for congestive heart failure after aortic valve replacement with a Carpentier-Edwards pericardial prosthesis in the elderly.

Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Bortier H.

J Heart Valve Dis. 2005 Nov;14(6):774-9.

PMID:
16359058
9.

Timing of aortic valve replacement in elderly patients with symptomatic aortic valve disease using outpatient clinical parameters.

Mistiaen W, Van Cauwelaert P, Sys SU, Muylaert P, Harrisson F, Bortier H.

Acta Clin Belg. 2005 Sep-Oct;60(4):185-9.

PMID:
16279399
10.

Risk factors and survival after aortic valve replacement in octogenarians.

Mistiaen W, Van Cauwelaert P, Muylaert P, Wuyts F, Harrisson F, Bortier H.

J Heart Valve Dis. 2004 Jul;13(4):538-44.

PMID:
15311858
11.

Effect of prior malignancy on survival after cardiac surgery.

Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Harrisson F, Bortier H.

Ann Thorac Surg. 2004 May;77(5):1593-7; discussion 1597.

PMID:
15111148
12.

Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis.

Mistiaen W, Van Cauwelaert P, Muylaert P, Sys SU, Harrisson F, Bortier H.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1166-70.

13.

Role of age, gender and association of CABG on long-term results after aortic valve replacement with a Carpentier-Edwards bioprosthesis in the elderly.

Mistiaen W, Van Cauwelaert P, Sys SU, Muylaert P, Harrisson F, Bortier H.

J Cardiovasc Surg (Torino). 2003 Dec;44(6):701-6.

PMID:
14735030
14.

Adding lactate to the prime solution during hypothermic cardiopulmonary bypass: a quantitative acid-base analysis.

Himpe D, Neels H, De Hert S, Van Cauwelaert P.

Br J Anaesth. 2003 Apr;90(4):440-5.

PMID:
12644414
15.

Determinants of survival after aortic valve replacement as treatment for symptomatic aortic valve disease in the elderly.

Mistiaen WP, Van Cauwelaert P, Muylaert P, Van Hove M, Sys SU, Harrisson F, Bunarto J, Delaruelle J, Bortier H.

J Heart Valve Dis. 2001 May;10(3):354-60.

PMID:
11380098
16.

High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery.

Van Tendeloo VF, Willems R, Ponsaerts P, Lenjou M, Nijs G, Vanhove M, Muylaert P, Van Cauwelaert P, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN.

Gene Ther. 2000 Aug;7(16):1431-7.

17.

Developmentally regulated responsiveness to transforming growth factor-beta is correlated with functional differences between human adult and fetal primitive hematopoietic progenitor cells.

Weekx SF, Plum J, Van Cauwelaert P, Lenjou M, Nijs G, De Smedt M, Vanhove M, Muylaert P, Van Bockstaele DR, Berneman ZN, Snoeck HW.

Leukemia. 1999 Aug;13(8):1266-72.

PMID:
10450756
18.

Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery.

Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D, Van Cauwelaert P.

Atherosclerosis. 1997 Jul 25;132(2):215-9.

PMID:
9242967
19.

Clinical evaluation of the oxygenation capacity and controllability of 15 commercially available membrane oxygenators during alpha-stat regulated hypothermic cardiopulmonary bypass.

Stinkens D, Himpe D, Thyssen P, De Bakker A, Smets W, Borms S, Suy M, Muylaert P, Van Hove M, Theunissen W, Van Cauwelaert P.

Perfusion. 1996 Nov;11(6):471-80.

PMID:
8971949
20.

[Cardiac myxoma in 13 patients].

Paelinck BP, Vermeersch PH, Convens CG, Van Cauwelaert PA, Van Den Branden FL.

Ned Tijdschr Geneeskd. 1995 Sep 23;139(38):1931-5. Dutch.

PMID:
7477533

Supplemental Content

Loading ...
Support Center